Role of Pro-Brain Natriuretic Peptide Serum Concentration in the Detection of Pulmonary Hypertension in Patients With End-Stage Lung Diseases Referred for Lung Transplantation

2018 ◽  
Vol 50 (7) ◽  
pp. 2044-2047
Author(s):  
J. Nowak ◽  
B. Hudzik ◽  
J. Niedziela ◽  
P. Rozentryt ◽  
M. Zembala ◽  
...  
Keyword(s):  
Pulmonary Hypertension ◽  
Serum Concentration ◽  
Brain Natriuretic Peptide ◽  
Lung Transplantation ◽  
Natriuretic Peptide ◽  
Lung Diseases ◽  
End Stage

Circulating Natriuretic Peptide Concentrations in Patients With End-Stage Renal Disease: Role of Brain Natriuretic Peptide as a Biomarker for Ventricular Remodeling

2001 ◽  
Vol 76 (11) ◽  
pp. 1111-1119 ◽  
Author(s):  
Alessandro Cataliotti ◽  
Lorenzo S. Malatino ◽  
Michihisa Jougasaki ◽  
Carmine Zoccali ◽  
Pietro Castellino ◽  
...  
Keyword(s):  
Renal Disease ◽  
Brain Natriuretic Peptide ◽  
Natriuretic Peptide ◽  
End Stage Renal Disease ◽  
Ventricular Remodeling ◽  
Stage Renal Disease ◽  
End Stage

scholarly journals Role of Transesophageal Echocardiography in Perioperative Patient Management of Lung Transplantation Surgery

2013 ◽  
Vol 1 (2) ◽  
pp. 48-56 ◽  
Author(s):  
Stephen A Esper
Keyword(s):  
Pulmonary Hypertension ◽  
Postoperative Complications ◽  
Lung Transplantation ◽  
Lung Disease ◽  
Transesophageal Echocardiography ◽  
Patient Management ◽  
Preoperative Evaluation ◽  
Transplantation Surgery ◽  
End Stage

ABSTRACT Lung transplantation is the only option for patients with end-stage lung disease. Chronic obstructive lung disease, idiopathic pulmonary fibrosis, cystic fibrosis and primary pulmonary hypertension are few common indications for lung transplantation. Patients with end-stage lung disease may have pre-existing cardiovascular compromise related to pulmonary hypertension and other cardiovascular lesions, such as coronary artery disease or valvular heart disease. Preoperative evaluation and optimization of hemodynamics is expected to improve outcomes from lung transplantation. Intraoperative hemodynamic instability is common during lung transplantation and requires highest level of cardiovascular monitoring. After transplantation, vascular anastomosis should be evaluated for flow patterns to rule out obstruction from stenosis or thrombosis. Postoperative complications are common and include bleeding, cardiac failure and hypoxemia from right to left shunt. Primary graft dysfunction may necessitate mechanical cardiorespiratory support. Transesophageal echocardiography plays a central role in preoperative evaluation, intraoperative hemodynamic management, evaluation of pulmonary vascular anastomosis, diagnosis of postoperative complications and also in the critical care management of mechanical cardiorespiratory support. How to cite this article Subramaniam K, Esper SA. Role of Transesophageal Echocardiography in Perioperative Patient Management of Lung Transplantation Surgery. J Perioper Echocardiogr 2013;1(2):48-56.

C-Reactive Protein, Interleukin 6, and N-Terminal Pro-Brain Natriuretic Peptide Following Cardioversion of Atrial Fibrillation: Is There a Role of Biomarkers in Arrhythmia Recurrence?

Angiology ◽  
2010 ◽  
Vol 62 (4) ◽  
pp. 310-316 ◽  
Author(s):  
Stavroula N. Psychari ◽  
Dionyssios Chatzopoulos ◽  
Efstathios K. Iliodromitis ◽  
Thomas S. Apostolou ◽  
Dimitrios T. Kremastinos
Keyword(s):  
Atrial Fibrillation ◽  
Brain Natriuretic Peptide ◽  
Natriuretic Peptide ◽  
Interleukin 6 ◽  
C Reactive Protein ◽  
Reactive Protein

Pulmonary Hypertension in End-Stage Pulmonary Fibrosis: Prevalence, Predictors and Survival before and after Lung Transplantation

2013 ◽  
Vol 32 (4) ◽  
pp. S18-S19 ◽  
Author(s):  
L. Bjurström ◽  
K.H. Andersen ◽  
J. Kjærgaard ◽  
M.P. Iversen ◽  
S. Boesgaard ◽  
...  
Keyword(s):  
Pulmonary Hypertension ◽  
Pulmonary Fibrosis ◽  
Lung Transplantation ◽  
Before And After ◽  
End Stage

Heart-lung transplantation is the method of choice in the treatment of patients with end-stage pulmonary hypertension

2002 ◽  
Vol 34 (6) ◽  
pp. 2181-2182 ◽  
Author(s):  
U.F.W Franke ◽  
T Wahlers ◽  
T Wittwer ◽  
T Franke ◽  
J Niedermeyer ◽  
...  
Keyword(s):  
Pulmonary Hypertension ◽  
Lung Transplantation ◽  
End Stage

Role of autoimmunity in organ allograft rejection: a focus on immunity to type V collagen in the pathogenesis of lung transplant rejection

2004 ◽  
Vol 286 (6) ◽  
pp. L1129-L1139 ◽  
Author(s):  
Tina L. Sumpter ◽  
David S. Wilkes
Keyword(s):  
Lung Transplantation ◽  
Lung Transplant ◽  
Transplant Rejection ◽  
Survival Rates ◽  
Definitive Treatment ◽  
Solid Organ ◽  
Type V Collagen ◽  
End Stage ◽  
Type V

Lung transplantation is the only definitive treatment modality for many forms of end-stage lung disease. However, the lung is rejected more often than any other type of solid organ allograft due to chronic rejection known as bronchiolitis obliterans (BO). Indeed, BO is the primary reason why the 5- and 7-yr survival rates are worse for the lung than for any other transplanted organ. Alloimmunity to donor antigens is established as the primary mechanism that mediates rejection responses. However, newer immunosuppressive regimens designed to abrogate alloimmune activation have not improved survival. Therefore, these data suggest that other antigens, unrelated to donor transplantation antigens, are involved in rejection. Utilizing human and rodent studies of lung transplantation, our laboratory has documented that a native collagen, type V collagen [col(V)], is a target of the rejection response. Col(V) is highly conserved; therefore, these data indicate that transplant rejection involves both alloimmune and autoimmune responses. The role of col(V) in lung transplant rejection is described in this review article. In addition, the potential role of regulatory T cells that are crucial to modulating autoimmunity and alloimmunity is also discussed.

Sign in / Sign up

Export Citation Format

Share Document